Published in Ann Clin Microbiol Antimicrob on October 20, 2004
Comparison of the sensitivity of culture, PCR and quantitative real-time PCR for the detection of Pseudomonas aeruginosa in sputum of cystic fibrosis patients. BMC Microbiol (2009) 1.05
Early eradication of Pseudomonas aeruginosa in patients with cystic fibrosis. Paediatr Respir Rev (2010) 1.03
A diagnostic PCR assay for the detection of an Australian epidemic strain of Pseudomonas aeruginosa. Ann Clin Microbiol Antimicrob (2010) 0.88
Comparison of culture and qPCR for the detection of Pseudomonas aeruginosa in not chronically infected cystic fibrosis patients. BMC Microbiol (2010) 0.87
Utility of aptamer-fluorescence in situ hybridization for rapid detection of Pseudomonas aeruginosa. Eur J Clin Microbiol Infect Dis (2010) 0.85
Proposal of a quantitative PCR-based protocol for an optimal Pseudomonas aeruginosa detection in patients with cystic fibrosis. BMC Microbiol (2013) 0.83
Detection of algD, oprL and exoA Genes by New Specific Primers as an Efficient, Rapid and Accurate Procedure for Direct Diagnosis of Pseudomonas aeruginosa Strains in Clinical Samples. Jundishapur J Microbiol (2014) 0.81
Proteomic identification of OprL as a seromarker for initial diagnosis of Pseudomonas aeruginosa infection of patients with cystic fibrosis. J Clin Microbiol (2009) 0.80
Drug resistance pattern of Pseudomonas aeruginosa strains isolated from cystic fibrosis patients at Isfahan AL Zahra hospital, Iran (2009-2010). Iran J Microbiol (2012) 0.79
Rapid detection of Pseudomonas aeruginosa targeting the toxA gene in intensive care unit patients from Beijing, China. Front Microbiol (2015) 0.79
Diagnostic and prognostic significance of systemic alkyl quinolones for P. aeruginosa in cystic fibrosis: A longitudinal study. J Cyst Fibros (2016) 0.78
Clinical application of a rapid microbiological test based on capillary zone electrophoresis to assess local skin infection. BMC Res Notes (2011) 0.75
Co-colonisation with Aspergillus fumigatus and Pseudomonas aeruginosa is associated with poorer health in cystic fibrosis patients: an Irish registry analysis. BMC Pulm Med (2017) 0.75
Lung infections associated with cystic fibrosis. Clin Microbiol Rev (2002) 9.20
Pseudomonas aeruginosa and other predictors of mortality and morbidity in young children with cystic fibrosis. Pediatr Pulmonol (2002) 4.85
Detection of Pseudomonas (Burkholderia) cepacia using PCR. Pediatr Pulmonol (1995) 2.44
PCR-based assay for differentiation of Pseudomonas aeruginosa from other Pseudomonas species recovered from cystic fibrosis patients. J Clin Microbiol (2004) 2.31
Risk assessment models and contamination management: implications for broad-range ribosomal DNA PCR as a diagnostic tool in medical bacteriology. J Clin Microbiol (2002) 2.08
Direct detection and identification of Pseudomonas aeruginosa in clinical samples such as skin biopsy specimens and expectorations by multiplex PCR based on two outer membrane lipoprotein genes, oprI and oprL. J Clin Microbiol (1997) 2.04
Pulmonary infections in patients with cystic fibrosis. Semin Respir Infect (2002) 2.01
Respiratory infections with Pseudomonas aeruginosa in children with cystic fibrosis: early detection by serology and assessment of risk factors. JAMA (2002) 1.76
Polymerase chain reaction for the detection of Pseudomonas aeruginosa, Stenotrophomonas maltophilia and Burkholderia cepacia in sputum of patients with cystic fibrosis. Mol Cell Probes (1996) 1.45
Pseudomonas acquisition in young patients with cystic fibrosis: pathophysiology, diagnosis, and management. Curr Opin Pulm Med (2003) 1.45
Detection of Pseudomonas aeruginosa from clinical and environmental samples by amplification of the exotoxin A gene using PCR. Appl Environ Microbiol (1994) 1.44
Molecular epidemiology of Pseudomonas aeruginosa. Front Biosci (2002) 1.15
Development of a diagnostic PCR assay that targets a heat-shock protein gene (groES) for detection of Pseudomonas spp. in cystic fibrosis patients. J Med Microbiol (2003) 0.92
A CFTR potentiator in patients with cystic fibrosis and the G551D mutation. N Engl J Med (2011) 8.73
Lumacaftor-Ivacaftor in Patients with Cystic Fibrosis Homozygous for Phe508del CFTR. N Engl J Med (2015) 5.51
Detection of anaerobic bacteria in high numbers in sputum from patients with cystic fibrosis. Am J Respir Crit Care Med (2008) 3.91
Lung clearance index is a repeatable and sensitive indicator of radiological changes in bronchiectasis. Am J Respir Crit Care Med (2014) 3.50
Campylobacter. Vet Res (2005) 2.74
Simvastatin decreases lipopolysaccharide-induced pulmonary inflammation in healthy volunteers. Am J Respir Crit Care Med (2009) 2.52
Extravascular lung water indexed to predicted body weight is a novel predictor of intensive care unit mortality in patients with acute lung injury. Crit Care Med (2010) 2.49
Lung microbiota and bacterial abundance in patients with bronchiectasis when clinically stable and during exacerbation. Am J Respir Crit Care Med (2013) 2.08
Risk assessment models and contamination management: implications for broad-range ribosomal DNA PCR as a diagnostic tool in medical bacteriology. J Clin Microbiol (2002) 2.08
Three drinking-water-associated cryptosporidiosis outbreaks, Northern Ireland. Emerg Infect Dis (2002) 2.04
The adult cystic fibrosis airway microbiota is stable over time and infection type, and highly resilient to antibiotic treatment of exacerbations. PLoS One (2012) 2.03
Molecular characterisation of the faecal microbiota in patients with type II diabetes. Curr Microbiol (2010) 1.92
An examination of antibacterial and antifungal properties of constituents described in traditional Ulster cures and remedies. Ulster Med J (2009) 1.92
Community-associated MRSA (CA-MRSA): an emerging pathogen in infective endocarditis. J Antimicrob Chemother (2007) 1.82
Treatment of lung infection in patients with cystic fibrosis: current and future strategies. J Cyst Fibros (2012) 1.79
A randomized clinical trial of hydroxymethylglutaryl- coenzyme a reductase inhibition for acute lung injury (The HARP Study). Am J Respir Crit Care Med (2010) 1.67
The epidemiology of antibiotic resistance in Campylobacter. Microbes Infect (2006) 1.51
Ocular pathogen or commensal: a PCR-based study of surface bacterial flora in normal and dry eyes. Invest Ophthalmol Vis Sci (2007) 1.47
Antibiotic prophylaxis, body piercing and infective endocarditis. J Antimicrob Chemother (2003) 1.45
Community-associated MRSA SCCmec type IVd in Irish equids. Vet Rec (2007) 1.44
MRSA in companion animals. Vet Rec (2006) 1.40
Respiratory viral infection in exacerbations of COPD. Respir Med (2008) 1.35
Cryptosporidiosis in developing countries. J Infect Dev Ctries (2007) 1.27
Loss of microbicidal activity and increased formation of biofilm due to decreased lactoferrin activity in patients with cystic fibrosis. J Infect Dis (2004) 1.25
Population structure and characterization of viridans group streptococci (VGS) including Streptococcus pneumoniae isolated from adult patients with cystic fibrosis (CF). J Cyst Fibros (2010) 1.17
Genotypes and subtypes of Cryptosporidium spp. in neonatal calves in Northern Ireland. Parasitol Res (2006) 1.17
Dysregulated apoptosis and NFkappaB expression in COPD subjects. Respir Res (2009) 1.12
Environmental stress and antibiotic resistance in food-related pathogens. Appl Environ Microbiol (2006) 1.11
Survival of epidemic strains of nosocomial- and community-acquired methicillin-resistant Staphylococcus aureus on coins. Am J Infect Control (2007) 1.10
Incidence and risk factors for pulmonary exacerbation treatment failures in patients with cystic fibrosis chronically infected with Pseudomonas aeruginosa. Chest (2011) 1.09
Recent advances in molecular epidemiology and detection of Taylorella equigenitalis associated with contagious equine metritis (CEM). Vet Microbiol (2003) 1.09
18FDG-positron emission tomography (PET) has a role to play in the diagnosis and therapy of infective endocarditis and cardiac device infection. Int J Cardiol (2013) 1.09
Decreased levels of secretory leucoprotease inhibitor in the Pseudomonas-infected cystic fibrosis lung are due to neutrophil elastase degradation. J Immunol (2009) 1.07
Asaia sp., an unusual spoilage organism of fruit-flavored bottled water. Appl Environ Microbiol (2002) 1.06
Evaluation of in vitro virulence characteristics of the genus Pandoraea in lung epithelial cells. J Med Microbiol (2008) 1.05
An outbreak of colonization with linezolid-resistant Staphylococcus epidermidis in an intensive therapy unit. J Antimicrob Chemother (2008) 1.04
Clinical trials in cystic fibrosis. J Cyst Fibros (2007) 1.03
A subset of patients with epithelial basement membrane corneal dystrophy have mutations in TGFBI/BIGH3. Hum Mutat (2006) 1.02
Multicenter randomized controlled trial of withdrawal of inhaled corticosteroids in cystic fibrosis. Am J Respir Crit Care Med (2006) 1.02
Towards "molecular Esperanto" or the Tower of Babel? (the need for harmonization of techniques for genotyping clinical isolates of Pseudomonas aeruginosa isolated from patients with cystic fibrosis). J Clin Microbiol (2003) 1.01
Proteomics analysis and protein expression during sporozoite excystation of Cryptosporidium parvum (Coccidia, Apicomplexa). Mol Cell Proteomics (2006) 1.01
Bacterial-protozoa interactions; an update on the role these phenomena play towards human illness. Microbes Infect (2005) 1.01
Antibiotic management of lung infections in cystic fibrosis. I. The microbiome, methicillin-resistant Staphylococcus aureus, gram-negative bacteria, and multiple infections. Ann Am Thorac Soc (2014) 1.00
Staphylococcus aureus enterotoxins induce IL-8 secretion by human nasal epithelial cells. Respir Res (2006) 1.00
Safety and efficacy of recombinant alpha(1)-antitrypsin therapy in cystic fibrosis. Pediatr Pulmonol (2006) 0.99
Comparison of techniques to examine the diversity of fungi in adult patients with cystic fibrosis. Med Mycol (2010) 0.99
Evidence for physical therapies (airway clearance and physical training) in cystic fibrosis: an overview of five Cochrane systematic reviews. Respir Med (2006) 0.98
Characterization and transfer of antibiotic resistance in lactic acid bacteria from fermented food products. Curr Microbiol (2011) 0.98
The effect of treatment of cystic fibrosis pulmonary exacerbations on airways and systemic inflammation. Pediatr Pulmonol (2007) 0.97
Evaluation of the ability of LL-37 to neutralise LPS in vitro and ex vivo. PLoS One (2011) 0.95
Molecular detection of CF lung pathogens: current status and future potential. J Cyst Fibros (2013) 0.95
The relationship of clinical and inflammatory markers to outcome in stable patients with cystic fibrosis. Pediatr Pulmonol (2007) 0.95
Biomarkers of fruit and vegetable intake in human intervention studies: a systematic review. Crit Rev Food Sci Nutr (2011) 0.94
Central line-related bacteremia due to Roseomonas mucosa in a patient with diffuse large B-cell non-Hodgkin's lymphoma. Leuk Lymphoma (2005) 0.94
Role of CFTR, Pseudomonas aeruginosa and Toll-like receptors in cystic fibrosis lung inflammation. Biochem Soc Trans (2009) 0.94
Improved laboratory diagnosis of bacterial and fungal infections in patients with hematological malignancies using PCR and ribosomal RNA sequence analysis. Leuk Lymphoma (2004) 0.93
Differences in invasion and translocation of Burkholderia cepacia complex species in polarised lung epithelial cells in vitro. Microb Pathog (2006) 0.93
Epidemiology of Burkholderia cepacia complex species recovered from cystic fibrosis patients: issues related to patient segregation. J Med Microbiol (2004) 0.93
Molecular characterization and phylogenetic analysis of quinolone resistance-determining regions (QRDRs) of gyrA, gyrB, parC and parE gene loci in viridans group streptococci isolated from adult patients with cystic fibrosis. J Antimicrob Chemother (2010) 0.93
Validity and reliability of cardiorespiratory measurements recorded by the LifeShirt during exercise tests. Respir Physiol Neurobiol (2009) 0.92
Development of a diagnostic PCR assay that targets a heat-shock protein gene (groES) for detection of Pseudomonas spp. in cystic fibrosis patients. J Med Microbiol (2003) 0.92
The potential misidentification of Tsukamurella pulmonis as an atypical Mycobacterium species: a cautionary tale. J Med Microbiol (2006) 0.91
Acute and latent adenovirus in COPD. Respir Med (2007) 0.91
Ureaplasma urealyticum CAPD peritonitis following insertion of an intrauterine device: diagnosis by eubacterial polymerase chain reaction. Perit Dial Int (2002) 0.91
Pseudomonas aeruginosa cystic fibrosis isolates of similar RAPD genotype exhibit diversity in biofilm forming ability in vitro. BMC Microbiol (2010) 0.90
Bronchial epithelial cell growth regulation in fibroblast cocultures: the role of hepatocyte growth factor. Am J Physiol Lung Cell Mol Physiol (2007) 0.90
Pandoraea apista isolated from a patient with cystic fibrosis: problems associated with laboratory identification. Br J Biomed Sci (2002) 0.90
Do smokers with chronic obstructive pulmonary disease report their smoking status reliably? A comparison of self-report and bio-chemical validation. Int J Nurs Stud (2011) 0.90
A rapid method for extracting oocyst DNA from Cryptosporidium-positive human faeces for outbreak investigations. J Microbiol Methods (2005) 0.90
Airway epithelial cell apoptosis and inflammation in COPD, smokers and nonsmokers. Eur Respir J (2012) 0.89
Molecular characterization of fecal microbiota in patients with viral diarrhea. Curr Microbiol (2011) 0.89
Comparison of nasal and bronchial epithelial cells obtained from patients with COPD. PLoS One (2012) 0.88
False identification of Coccidioides immitis: do molecular methods always get it right? J Clin Microbiol (2003) 0.88
Antimicrobial activity of Calendula officinalis petal extracts against fungi, as well as Gram-negative and Gram-positive clinical pathogens. Complement Ther Clin Pract (2012) 0.88
An examination of antibacterial and antifungal properties of constituents of Shiitake (Lentinula edodes) and oyster (Pleurotus ostreatus) mushrooms. Complement Ther Clin Pract (2008) 0.88